$5.11-81.01% · 3M
Moving avg
1W-5.55%
1M-0.39%
3M-82.12%
6M-83.63%
YTD-75.12%
1Y-59.76%
3Y+1194.52%
5Y+2119.23%
52-week range
$4.511% of range$69.00
Company health
Value0/6
Growth0/6
Profitability0/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Net cash on the balance sheet
Risks
- Burning free cash flow
Key statistics
Valuation
Market cap
$2.53B
Enterprise value
$2.51B
P/E ratio (TTM)
-356.34x
P/S ratio (TTM)
0.00x
EV/EBITDA
-356.34x
Per share & returns
EPS (TTM)
-$0.01
Dividend yield
0.00%
Beta (1Y)
1.49
30-day change
-0.39%
Trading
Volume (24h)
90.88K
Previous close
$5.06
Shares outstanding
495.47M
About Regencell Bioscience Holdings Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Symbol
RGC
Regencell Bioscience Holdings Limited is a mid-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on NASDAQ (Hong Kong) and trade under the ticker RGC.
Frequently asked questions
What is Regencell Bioscience Holdings Limited's market cap?
Regencell Bioscience Holdings Limited (RGC) has a market capitalization of $2.53B.
What sector is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited operates in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
What exchange does RGC trade on?
RGC trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap